LIVN Q2 2020 Earnings — LivaNova PLC Revenue & Financial Results | Market Cap Arena

LIVNLivaNova PLC

$3B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$182M-34.3% YoY

Gross Profit

$116M63.9% margin

Operating Income

-$15M-8.4% margin

Net Income

-$88M-48.3% margin

EPS (Diluted)

$-1.81

QoQ Revenue Growth

-24.8%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$28M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$2.5B

Total Liabilities

$1.2B

Stockholders' Equity

$1.3B

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$182M	$277M	-34.3%
Gross Profit	$116M	$197M	-40.9%
Operating Income	-$15M	-$30M	+49.0%
Net Income	-$88M	-$29M	-201.2%

Revenue Segments

Cardiovascular Segment

$125M69%

Neuromodulation Segment

$57M31%

Geographic Segments

UNITED STATES

$78M43%

Locations Excluding The United States And Europe

$69M38%

Europe

$35M19%